Literature DB >> 17508180

Pharmacological treatment compared to behavioural treatment for juvenile tension-type headache: results at two-year follow-up.

F Andrasik1, L Grazzi, S Usai, G Bussone.   

Abstract

Recurrent headaches are common in children and adolescents. Most current investigations have employed limited modalities (either medication or behavioural) and few have included comparisons of different treatments. In this study relaxation training, administered in a limited contact format, and amitriptyline were compared for juvenile episodic tension-type headache. The clinical improvement was significant for both groups at 1- and 2-year follow-up; in particular for behavioural treatment, the patients came regularly for the sessions, practised routinely, and appeared to be compliant and accepting of treatment, although we did not assess this formally. In this group of patients the percentage of drop-outs was lower than in the pharmacological tratment. Although clinical results were similar in both groups, relaxation therapy seems to be more accepted than medication. The limited contact modality seems to be as useful as other behavioural approaches that require a greater investment of time (by patients and therapists), without unpleasant side effects. Because the sample sizes are small, these conclusions are tentative.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17508180     DOI: 10.1007/s10072-007-0786-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  14 in total

Review 1.  Treatment adherence in patients with headache: a systematic review.

Authors:  Rachelle R Ramsey; Jamie L Ryan; Andrew D Hershey; Scott W Powers; Brandon S Aylward; Kevin A Hommel
Journal:  Headache       Date:  2014-04-17       Impact factor: 5.887

Review 2.  Psychological issues in the evaluation and treatment of tension-type headache.

Authors:  Noah L Rosen
Journal:  Curr Pain Headache Rep       Date:  2012-12

Review 3.  Tension-type headache.

Authors:  Sait Ashina; Dimos D Mitsikostas; Mi Ji Lee; Nooshin Yamani; Shuu-Jiun Wang; Roberta Messina; Håkan Ashina; Dawn C Buse; Patricia Pozo-Rosich; Rigmor H Jensen; Hans-Christoph Diener; Richard B Lipton
Journal:  Nat Rev Dis Primers       Date:  2021-03-25       Impact factor: 52.329

4.  Treatment Adherence in Child and Adolescent Chronic Migraine Patients: Results From the Cognitive-Behavioral Therapy and Amitriptyline Trial.

Authors:  Ashley M Kroon Van Diest; Rachelle R Ramsey; Susmita Kashikar-Zuck; Shalonda Slater; Kevin Hommel; John W Kroner; Susan LeCates; Marielle A Kabbouche; Hope L O'Brien; Joanne Kacperski; Janelle R Allen; James Peugh; Andrew D Hershey; Scott W Powers
Journal:  Clin J Pain       Date:  2017-10       Impact factor: 3.442

5.  An innovative approach for migraine prevention in young age: a preliminary study.

Authors:  Susanna Usai; Licia Grazzi; Frank Andrasik; Gennaro Bussone
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

6.  Self-help group and medication overuse headache: preliminary data.

Authors:  Elisa Sancisi; Marialuisa Rausa; Stefano Zanigni; Sabina Cevoli; Andrea Norcini Pala; Marianna Nicodemo; Daniela Grimaldi; Pasquale Montagna; Pietro Cortelli; Giulia Pierangeli
Journal:  Neurol Sci       Date:  2009-09-19       Impact factor: 3.307

Review 7.  Complementary and alternative approaches to the treatment of tension-type headache.

Authors:  Christina Sun-Edelstein; Alexander Mauskop
Journal:  Curr Pain Headache Rep       Date:  2012-12

Review 8.  Complementary and alternative approaches to the treatment of tension-type headache.

Authors:  Christina Sun-Edelstein; Alexander Mauskop
Journal:  Curr Pain Headache Rep       Date:  2008-12

Review 9.  Psychological issues in the evaluation and treatment of tension-type headache.

Authors:  Noah L Rosen
Journal:  Curr Pain Headache Rep       Date:  2008-12

10.  Gingkolide B as migraine preventive treatment in young age: results at 1-year follow-up.

Authors:  Susanna Usai; Licia Grazzi; Gennaro Bussone
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.